Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Wellness Journal Romania.
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial
STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Europe Clinical Nutrition Market Set to Reach $36.63B by 2033, Driven by Chronic Illness Care & Personalized Solutions
Rising chronic diseases, aging populations, and innovation in personalized nutrition propel Europe’s clinical nutrition market growth through 2033. AUSTIN, TX, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- The Europe clinical nutrition...
Serratia Marcescens Outbreak Kills Six Infants in Romania Hospital
(MENAFN) Six infants have died and three more have tested positive following a Serratia marcescens outbreak at the Sfanta Maria Children's Hospital in the northeastern Romanian city of Iasi, the country's Health Ministry announced Friday. A total...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
ATHENS, Greece and SOLANA BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in EMEA region, today announced that it has signed an agreement...
Gold Nanoparticles and DNA, a Revolutionary Duo for Medicine: Nanoconjugates in the Fight with Cancer and Other Diseases
The nanoconjugates, known as nanobeacons and nano-flares, open up new horizons for rapid and accurate disease diagnosis and targeted therapies. CLUJ-NAPOCA, ROMANIA, September 18, 2025 /EINPresswire.com/ -- An innovative study published in the...
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland
STAFFORD, Texas, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Cord Blood Banking Services Market Size Expected to Reach USD 5.81 Billion by 2034 Driven by Regenerative Medicine and Chronic Disease Therapies
Ottawa, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The worldwide cord blood banking services market size is expected to reach approximately USD 5.81 billion by 2034, increasing from USD 3.27 billion in 2025. The market is growing at a compound annual...
ECDC Warns: Drug-Resistant Fungus Spreads Across Europe Hospitals
(MENAFN) The European Centre for Disease Prevention and Control (ECDC) confirmed Thursday that a dangerous, drug-resistant fungus is making alarming inroads within hospitals across Europe. In its latest report, the ECDC revealed that Candida auris...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
EMBRACE Future launches #KnowEmotions Public Awareness-Raising Campaign on Children’s Mental Health
BUCHAREST, ROMANIA, September 11, 2025 /EINPresswire.com/ -- The EMBRACE project team is proud to announce the launch of its Public Awareness-Raising Campaign (PAC), running from October 2025 until April 2026. The campaign, under the motto...
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain...
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US 13 subjects recruited (treated, enrolled, or screened) Forecasts total recruitment of 20 or more subjects by end of September On track to recruit to...
PainReform Provides Business Update for the Six Months Ended June 30, 2025
TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today...
In Madrid and Melilla, NATO Parliamentarians Spotlight Shared Security Challenges on Europe’s Southern Flank
01 October 2025 Security on the Southern Flank is inseparable from that of the entire Alliance: challenges such as migration, terrorism and instability in NATO’s neighbourhood impact all Allies and demand collective responses. In a visit to Madrid...
Owner: NATO Parliamentary Assembly
Winners of the 2025 Esomar Awards are announced in Prague
Global brands, agencies, and innovators recognised for groundbreaking work in research, data, and insights at Esomar’s annual Congress PRAGUE, CZECH REPUBLIC, September 30, 2025 /EINPresswire.com/ -- Esomar, the global community for data,...
Progesterone Market Size Drives at 12.74% CAGR to Hit USD 5.05 Billion by 2034
Ottawa, Sept. 08, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister firm of Precedence Research, the global progesterone market size was valued at USD 1.52 billion in 2024 and is expected to reach USD 5.05 billion by...
2025 Sees Historic Surge in Heat Fatalities Across Europe
(MENAFN) Heat-related fatalities in European cities have surged more than threefold this year, driven by human-induced climate change, according to a new report released Wednesday. The research, conducted by Imperial College London and the London...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
Spain site opens with two R/R AML subjects enrolled; One treated On track to recruit 45 subjects in 4Q25 for initial data unblinding HOUSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the...
Christine Valmy, Architect of the U.S. Esthetics Industry, Celebrates 60 Years
PINE BROOK, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Christine Valmy, the company that established the professional esthetics industry in the United States, proudly celebrates 60 years of shaping beauty education, advancing skin health, and...
Africa Lead-Acid Battery Market Set to Double by 2035: Key Growth Drivers Explained | Analysis Report by TMR
Africa's lead-acid battery market accounts for a critical part of the energy and power storage market in the region. WILMINGTON, DE, UNITED STATES, September 15, 2025 /EINPresswire.com/ -- The Africa Lead-Acid Battery Market is poised for...